Don't know ?
I would think there are about 10 people that read Isaac's post
ya think that would move the needle ?
New SI Covering
From the pages of " Book of Biotech "
inducements, motivations, encouragements, spurs, reasons, lures, stimuli, carrots, catalysts, come-ons, considerations, determinants, drives, excuses, exhortations, goads, grounds, impulses, influences, inspirations, motives, persuasions, provocations, purposes, rationales, springs, stimulants, temptations, urges, whips
All in the name of Money.
You only need to catch a coat tail *
Lymphoma and Plasma Cell Disorders
Session Type: Poster Session
Track(s): Lymphoma and Plasma Cell Disorders
Phase I/II study of intratumoral injection of SD-101, an immunostimulatory CpG, and intratumoral injection of ipillumumab, an anti-CTLA-4 monoclonal antibody, in combination with local radiation in low-grade B-cell lymphomas.
Michael Siavash Khodadoust, MD, PhD
It's closing in, Time and decision making.
There's a lot of leverage to make some large moves in the stock
And I Think it's not in a downward motion.
Enjoy the ride * Been a LONG time coming
DVAX has over 160 Million Dollars Short
We went under 1.00, I would bet 90% plus short is under water as of today.
What do you think it would cost to have The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of Dynavax Technologies From 012 / 013
Pocket change compared to 160 Million Dollars
The Firm’s ( investigation ) relates to ( potential damages ) to Dynavax caused by ( allegedly ) false and misleading public statements by the Company’s senior officers and directors regarding Dynavax’s Hepatitis B vaccine, “HEPISLAV”. These ( alleged ) false and misleading statements, when made public, led to the drop in Dynvax’s stock price and the filing of a class action lawsuit against the Company.
Big money has deep pockets and they would love to have any contribution your willing to donate.
Here are some other tricks of Hedge funds
One of the easiest ways for hedge funds to make money is to short the stock of a company seeking to raise money through an equity financing. The hedge fund then buys shares in the company's offering -- at a lower price -- and covers its short for a quick profit.
Drug makers are getting more and more nervous that hedge funds have found a way to make money by putting their patents in jeopardy.
Taking advantage of new rules created by Congress three years ago, hedge funds have increasingly been filing challenges to pharmaceutical patents. Some may be angling for payouts to drop their claims, while others are shorting the stock, betting that the manufacturers’ shares will plummet.
In a filing with the SEC dated Feb. 19, Retrophin shared preliminary findings of an internal probe following the abrupt ouster last October of Shkreli, a controversial short-seller who flipped and took the ultimate long position—starting his own publicly traded company and becoming its CEO. The company told the SEC its board has found that, at Shkreli's behest, Retrophin had disguised legal settlements with (former investors) as "consulting agreements." According to the SEC disclosure, Shkreli also used company cash to resolve legal claims against himself and a hedge fund he ran.
Standard Form for the firm
BOULDER, Colo., Mar 02, 2015 -- The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of INSYS Therapeutics, Inc. INSYS is an Arizona-based specialty pharmaceutical company.
If you currently own INSYS common stock and are interested in discussing your rights, or have information relating to this investigation,
Use some logic here
Any filing of a recent class action lawsuit against the Company would have been all over the press
And for Dynavax to ask a federal judge for a motion to dismiss the class action would take months if not a year or s,.From the point the class was put on to the dismissal request.
I suggest you do a search on Shuman Law Firm
Enjoy your weekend *
Filing of all class action lawsuit against the Company are public information.
Check it out
Or write PR dept.
The CT is from March 5th 10-K, If you did some DD you would see we have done these in our past filings.
The Law suit is old hat from 013
Cant keep a GOOD Co down can Ya *
Associate Director, QA Compliance ( Dynavax )
I came to Dynavax from a large Pharmaceutical company and was not sure what to expect. Since joining Dynavax in July 2013, it's been a wonderful experience. We are a fast growing company; continuing to build and strengthen our quality system while creating strong teams in preparation for our anticipated commercial launch. It's exciting to be part of the Dynavax team!